Kobo Biotech Limited

KOBO

INE881A01015

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:57 02/07/2024 pm IST			5-day change	1st Jan Change
4.09 ^INR	+4.87%		-2.15%	+31.94%

28/06	Kobo Biotech Limited Announces Resignation of Jignesh Patel as Company Secretary and Compliance Officer	CI
30/05	Kobo Biotech Limited Announces Resignation of Abhishek Buddhadev as Non-Executive and Independent Director	CI

Kobo Biotech Limited Announces Resignation of Abhishek Buddhadev as Non-Executive and Independent Director

May 30, 2024 at 04:02 pm IST

Kobo Biotech Limited announced that Mr. Abhishek Buddhadev has tendered his resignation as Non-Executive and Independent Director of the Company with effect from close of business hours on 30 May, 2024 due to other professional commitments.

Latest news about Kobo Biotech Limited

Kobo Biotech Limited Announces Resignation of Jignesh Patel as Company Secretary and Compliance Officer	28/06	CI
Kobo Biotech Limited Announces Resignation of Abhishek Buddhadev as Non-Executive and Independent Director	30/05	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11	CI
Kobo Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Kobo Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/23/30	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Kobo Biotech Limited Announces Change in Registered Office Address	12/22/12	CI
Kobo Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11/22/11	CI
Kobo Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/22/30	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/22/14	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	08/21/08	CI
Kobo Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	13/21/13	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	30/21/30	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	12/21/12	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	13/20/13	CI
Avon Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	15/20/15	CI
Avon Lifesciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	30/20/30	CI
Avon Lifesciences Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/20/14	CI
Avon Lifesciences Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/19/14	CI
Avon Lifesciences Limited Changes Registered Office Address	09/19/09	CI

Chart Kobo Biotech Limited

Duration

Period

More charts

Company Profile

Kobo Biotech Limited is an India-based company. The Company's business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company has no operational activities being carried out at its Solapur site, India.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KOBO BIOTECH LIMITED	+31.94%	1.11M
ELI LILLY AND COMPANY	+54.87%	823B
NOVO NORDISK A/S	+42.31%	641B
JOHNSON & JOHNSON	-6.89%	352B
MERCK & CO., INC.	+17.18%	324B
ABBVIE INC.	+7.64%	301B
ASTRAZENECA PLC	+14.02%	241B
ROCHE HOLDING AG	+1.64%	223B
NOVARTIS AG	+13.66%	218B
AMGEN INC.	+8.36%	167B